Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Curium Announces the Submission of its Marketing Authorization Application for [18F]-DCFPyL to the European Medicines Agency

Read more ››
By: GlobenewsWire - 27 Jun 2022

Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma

Read more ››
By: PR Newswire Association LLC. - 27 Jun 2022

27 winners receive the 2022 MAP Award for high performance in revenue cycle 

Read more ››
By: GlobenewsWire - 27 Jun 2022

Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease

Read more ››
By: PR Newswire Association LLC. - 27 Jun 2022

Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Read more ››
By: PR Newswire Association LLC. - 27 Jun 2022

SPR Therapeutics Named a Top Workplace

Read more ››
By: GlobenewsWire - 26 Jun 2022

FinThrive™ Announces New Autonomous Revenue Management Research and Speaking Sessions at HFMA Annual Conference 2022

Read more ››
By: PR Newswire Association LLC. - 26 Jun 2022

Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application

Read more ››
By: PR Newswire Association LLC. - 26 Jun 2022

Researchers Continue Study of COVID-19 Vaccinations in Pregnant People

Read more ››
By: PR Newswire Association LLC. - 26 Jun 2022

ABC Issues Statement on Supreme Court Decision in Dobbs V. Jackson

Read more ››
By: PR Newswire Association LLC. - 26 Jun 2022

Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program

Read more ››
By: GlobenewsWire - 25 Jun 2022

Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™

Read more ››
By: GlobenewsWire - 25 Jun 2022

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

Read more ››
By: GlobenewsWire - 25 Jun 2022

Antios Therapeutics' ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study; ATI-1428 and ATI-1645 Exhibit Potent Antiviral Activity in a Nonclinical Study

Read more ››
By: PR Newswire Association LLC. - 25 Jun 2022

Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™

Read more ››
By: PR Newswire Association LLC. - 25 Jun 2022

Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™

Read more ››
By: GlobenewsWire - 25 Jun 2022

Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update

Read more ››
By: GlobenewsWire - 25 Jun 2022

Jushi Holdings Inc. Amends and Refiles Q1 2022 Financial Statements

Read more ››
By: GlobenewsWire - 25 Jun 2022

Todos Medical Releases Preliminary Data from IRB-Waived Tollovid® Market Research Study in Acute and Long COVID

Read more ››
By: PR Newswire Association LLC. - 25 Jun 2022

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

Read more ››
By: GlobenewsWire - 25 Jun 2022
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate